Masafumi Sugitani

528 total citations
7 papers, 459 citations indexed

About

Masafumi Sugitani is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Masafumi Sugitani has authored 7 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Orthopedics and Sports Medicine. Recurrent topics in Masafumi Sugitani's work include Bone health and osteoporosis research (3 papers), Bone Metabolism and Diseases (3 papers) and Bone health and treatments (2 papers). Masafumi Sugitani is often cited by papers focused on Bone health and osteoporosis research (3 papers), Bone Metabolism and Diseases (3 papers) and Bone health and treatments (2 papers). Masafumi Sugitani collaborates with scholars based in Japan. Masafumi Sugitani's co-authors include Kazuhito Kawabata, Mayumi Suzuki, Masaaki Toda, Katsuhiro Imaki, Tsumoru Miyamoto, Sawao Murao, Ken-ichi Fukuhara, Kōhei Oda, Hiroyuki Yamada and Satoshi Nishikawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Bone.

In The Last Decade

Masafumi Sugitani

7 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masafumi Sugitani Japan	5	196	100	100	98	74	7	459
Liang Deng China	15	327 1.7×	38 0.4×	74 0.7×	62 0.6×	74 1.0×	42	521
Keisuke Nagatsuma Japan	11	113 0.6×	101 1.0×	71 0.7×	83 0.8×	23 0.3×	20	431
Huayi Huang United States	13	217 1.1×	56 0.6×	167 1.7×	36 0.4×	102 1.4×	31	488
Joseph P. Abraham United States	11	129 0.7×	68 0.7×	65 0.7×	74 0.8×	37 0.5×	19	601
Hana Lee South Korea	13	262 1.3×	99 1.0×	89 0.9×	38 0.4×	113 1.5×	31	519
Zhuo Gao China	17	283 1.4×	63 0.6×	76 0.8×	128 1.3×	193 2.6×	36	588
Denise L. Cecil United States	14	278 1.4×	54 0.5×	200 2.0×	240 2.4×	78 1.1×	29	621
Amanda Moyer United States	6	139 0.7×	55 0.6×	76 0.8×	138 1.4×	70 0.9×	10	590
Ya-Wen Hsiao Taiwan	11	309 1.6×	193 1.9×	229 2.3×	142 1.4×	108 1.5×	16	733
Shumei Ren United States	11	266 1.4×	62 0.6×	132 1.3×	187 1.9×	74 1.0×	14	595

Countries citing papers authored by Masafumi Sugitani

Since Specialization

Citations

This map shows the geographic impact of Masafumi Sugitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Sugitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Sugitani more than expected).

Fields of papers citing papers by Masafumi Sugitani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Sugitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Sugitani. The network helps show where Masafumi Sugitani may publish in the future.

Co-authorship network of co-authors of Masafumi Sugitani

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Sugitani. A scholar is included among the top collaborators of Masafumi Sugitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Sugitani. Masafumi Sugitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

OCHI, Yasuo, Hiroyuki Yamada, Hiroshi Mori, et al.. (2014). Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized cynomolgus monkeys. Bone. 65. 1–8. 20 indexed citations

2.

OCHI, Yasuo, Hiroyuki Yamada, Hiroshi Mori, et al.. (2011). Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism. Bone. 49(6). 1351–1356. 41 indexed citations

3.

OCHI, Yasuo, Hiroyuki Yamada, Satoshi Nishikawa, et al.. (2011). Efficacy of ONO-5334, a cathepsin K inhibitor, on bone turnover and cortical geometry in ovariectomized cynomolgus monkeys. Bone. 48. S72–S72. 1 indexed citations

4.

Yamada, Hiroyuki, Yasuo OCHI, Satoshi Nishikawa, et al.. (2011). Efficacy of ONO-5334, a cathepsin K inhibitor, on bone mass and strength in ovariectomized cynomolgus monkeys. Bone. 48. S221–S221. 3 indexed citations

5.

Macina, Orest T., et al.. (1995). Discovery of Potent Cyclic GMP Phosphodiesterase Inhibitors. 2-Pyridyl- and 2-Imidazolylquinazolines Possessing Cyclic GMP Phosphodiesterase and Thromboxane Synthesis Inhibitory Activities. Journal of Medicinal Chemistry. 38(18). 3547–3557. 29 indexed citations

6.

Kawabata, Kazuhito, Mayumi Suzuki, Masafumi Sugitani, et al.. (1991). ONO-5046, a novel inhibitor of human neutrophil elastase. Biochemical and Biophysical Research Communications. 177(2). 814–820. 313 indexed citations

7.

Oda, Kōhei, Masafumi Sugitani, Ken-ichi Fukuhara, & Sawao Murao. (1987). Purification and properties of a pepstatin-insensitive carboxyl proteinase from a Gram-negative bacterium. Biochimica et Biophysica Acta (BBA) - General Subjects. 923(3). 463–469. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact